- Home
- VMAR vs APVO Comparison
VMAR vs APVO Comparison
Compare VMAR & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VMAR
- APVO
- Stock Information
- Founded
- VMAR 1995
- APVO 2016
- Country
- VMAR Canada
- APVO United States
- Employees
- VMAR N/A
- APVO N/A
- Industry
- VMAR Marine Transportation
- APVO Biotechnology: Pharmaceutical Preparations
- Sector
- VMAR Industrials
- APVO Health Care
- Exchange
- VMAR Nasdaq
- APVO Nasdaq
- Market Cap
- VMAR 5.1M
- APVO 4.1M
- IPO Year
- VMAR 2020
- APVO N/A
- Fundamental
- Price
- VMAR $6.60
- APVO $3.06
- Analyst Decision
- VMAR Strong Buy
- APVO Strong Buy
- Analyst Count
- VMAR 1
- APVO 1
- Target Price
- VMAR $2,700.00
- APVO $5,920.00
- AVG Volume (30 Days)
- VMAR 39.6K
- APVO 191.0K
- Earning Date
- VMAR 07-11-2025
- APVO 08-07-2025
- Dividend Yield
- VMAR N/A
- APVO N/A
- EPS Growth
- VMAR N/A
- APVO N/A
- EPS
- VMAR N/A
- APVO N/A
- Revenue
- VMAR $1,128,568.00
- APVO N/A
- Revenue This Year
- VMAR N/A
- APVO N/A
- Revenue Next Year
- VMAR $264.29
- APVO N/A
- P/E Ratio
- VMAR N/A
- APVO N/A
- Revenue Growth
- VMAR N/A
- APVO N/A
- 52 Week Low
- VMAR $4.04
- APVO $2.81
- 52 Week High
- VMAR $675.00
- APVO $381.10
- Technical
- Relative Strength Index (RSI)
- VMAR 48.62
- APVO 38.28
- Support Level
- VMAR $5.74
- APVO $3.01
- Resistance Level
- VMAR $6.28
- APVO $3.18
- Average True Range (ATR)
- VMAR 0.34
- APVO 0.16
- MACD
- VMAR 0.06
- APVO 0.19
- Stochastic Oscillator
- VMAR 68.98
- APVO 45.45
About VMAR Vision Marine Technologies Inc.
Vision Marine Technologies Inc is in the business of designing and manufacturing electric outboard powertrain systems, power boats, and related technology and the renting of electric boats. The different models of the powerboats and electric boats manufactured by the company include Bruce 22, Fantail 217, Volt 180, and others. The company operates in two reportable business segments; Sale of electric boats and Rental of electric boats. The majority of the revenue for the company is generated from the Sale of electric boats segment. Geographically, the company generates revenue from its business in Canada, USA and other countries. A substantial portion of the overall revenue is generated from its business in USA.
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.